BCL2 and central nervous system cancer: The results indicated that the fluorescence activity of Bcl-2-WT could be inhibited by miR-384-agomiR, and the Bcl-2 mRNA and protein expression in glioma cells transfected with miR-384-agomiR was obviously inhibited (Figure 3E, 3F).